In contrast, classification of breast cancer patients based on tumor subtype found that fluvastatin treatments reduced proliferation rates and induced apoptosis in high-grade breast cancers37, and that patients taking lipophilic statins were less likely to develop estrogen receptor-negative (ER-) breast cancer38. This evidence concerns the gene ESR1 and breast carcinoma.